The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia

BACKGROUND: A previous study reported that the myosin regulatory light chain interacting protein (MYLIP) might serve as a novel therapeutic class for treating dyslipidemia. It contributes to variations in the levels of circulating low-density lipoprotein cholesterol (LDL-C), promoting the degradatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Paulo C.J.L., Morgan, Aline C., Jannes, Cinthia E., Krieger, José E., Santos, Raul D., Pereira, Alexandre C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206345/
https://www.ncbi.nlm.nih.gov/pubmed/25171759
http://dx.doi.org/10.1097/FPC.0000000000000089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206345/
https://www.ncbi.nlm.nih.gov/pubmed/25171759
http://dx.doi.org/10.1097/FPC.0000000000000089

Ejemplares similares